Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene
ICD-10 E09.52 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene.
E09.52 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by the presence of diabetic peripheral angiopathy that has progressed to gangrene. This condition arises when certain medications or toxic substances disrupt normal glucose metabolism, leading to hyperglycemia and subsequent complications. Diabetic peripheral angiopathy is a vascular complication that affects blood flow to the extremities, resulting in ischemia, tissue damage, and potentially gangrene. Patients may present with symptoms such as pain, numbness, and ulcers in the feet or legs. The management of this condition requires careful monitoring of blood glucose levels, often through HbA1c testing, and may necessitate insulin therapy or other antidiabetic medications. The presence of gangrene indicates a severe complication that may require surgical intervention, such as debridement or amputation, to prevent systemic infection and further morbidity.
Detailed medication history, HbA1c levels, and complications must be documented.
Patients presenting with uncontrolled diabetes due to medication, requiring insulin management.
Endocrinologists must ensure that the cause of diabetes is clearly documented to support the use of E09.52.
Documentation of foot ulcers, gangrene, and treatment plans.
Patients with diabetic foot ulcers or gangrene requiring surgical intervention.
Podiatrists should document the vascular status and any interventions performed to support coding.
Used for follow-up visits for management of drug-induced diabetes.
Document the patient's medication history, HbA1c levels, and any complications.
Endocrinologists should ensure comprehensive documentation of diabetes management.
Common drugs that can induce diabetes include corticosteroids, certain antipsychotics, and some medications used in cancer treatment. It is important to document the specific drug responsible for accurate coding.